פרופופול 1% פרזניוס - Propofol 1% fresenius
ש××× ×× !
×ת×ר××: 16/06/2024 ×תק××× ××××¢× ×× ×©×××ק ×תר××¤× ××פסק ×צ××ת×ת.
×ת×ר××: 16/06/2024 ×תק××× ××××¢× ×× ×©×××ק ×תר××¤× ××פסק ×צ××ת×ת.
×ק×ר: ××©×¨× ××ר×××ת - ××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | N01AX Other general anesthetics |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ת××-×ר××× - I.V |
| צ×רת ××× ×× | ת×××× ××××¨×§× ×× ××× ×¤××××, EMULSION FOR INJECTION OR INFUSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Propofol 1% is a short-acting intravenous general anaesthetic for:⢠induction and maintenance of general anaesthesia in adults and children > 1 month⢠sedation of ventilated patients >16 years of age in the intensive care unit⢠sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month. |
| ×ת××ת ××× ×× | Posology and method of administration |
| ×ת××××ת × ×× | Contraindications |
| ת×פע×ת ××××× | Undesirable effects |
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction |
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation |
| פר×ק×××× ×××§× | Pharmacodynamic Properties |
| פר×ק×ק×× ×××§× | Pharmacokinetic Properties |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  |
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| פר×פ×פ×× 1% פר×× ××ס ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | FRESENIUS KABI DEUTSCHLAND GMBH, GERMANY |
| ×©× ××¢× ×ר×ש×× | CURE MEDICAL & TECHNICAL SUPPLY |
| ר×ש××× | ת×ר×× ××ש×: 10/2000. ר×ש××× ×ת×ר××: 05/2014 |
| ת×ר×× ×¢×××× ××ר×× | 16/06/2024 |
השינוי האחרון נעשה בֹ־4 בספטמבר 2024 ב־05:14